When the Supreme Court ended a woman’s right to abortion in 2022, it was hard to believe access to contraceptives could follow. And yet, even before the election, legislative initiatives had begun to limit access to certain contraceptives. A Trump administration could continue this regressive path, which could suggest a slippery slope to 1960s back-alley brutality.
It’s time for men to do their part. After 70 years of research, several new male birth control options are succeeding in clinical studies. Accelerating their development could slow the ongoing assault on women’s reproductive health. But this requires a new regulatory perspective, more research funding, and a commitment to prioritizing innovation in a market that’s been stagnant for more than half a century.
